Teva Pharmaceuticals on Twitter: "Dr. Michael Hayden, head of Teva's global R&D, meets with #HuntingtonsDisease patients and their families at the Vatican. #Hddennomore. https://t.co/LeojD4GEDe" / Twitter
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Meet the Investigator – HD Insights
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture | Ctech
Michael Hayden, MD, PhD - World Neuroscience Innovation Forum
Troubled Drugmaker Teva to Axe over 4,000 Jobs | Ctech
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
ABOUT US | Prilenia Therapeutics
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
Israel Ministry of Foreign Affairs - Premier Kathleen Wynne visited Teva Pharmaceutical Industries Ltd., where she met with Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer. Israeli Teva is
VIP Reception
Michael Hayden Net Worth (2023) | wallmine
Michael R. Hayden - Wikipedia
Teva CEO promises to reshape, refocus company | Reuters
Prilenia Therapeutics raises $62.5m, names Michael Hayden CEO - Globes
Incisive Genetics
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
Michael Hayden - News, Articles, Whitepapers - Drug Target Review
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva In Transition: Generics, Specialty And 'The Space Between' :: Scrip
Axovant poaches Allergan's and Teva's chief medical and science officers - PMLiVE
Michael Hayden - Director at n-Lorem Foundation | The Org
Teva Goes High Tech to Deliver Medicine Through Implanted Microchip | Messianic Bible
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
Michael Hayden - Principal @ Chertoff Group - Recent News and Activity
Teva shares surge on corporate shake-up - MarketWatch
